Glaxosmithkline
- All
- News
- Videos
-
Pharma Giant GSK Fires Employee After Video Of His Abusive Meltdown On Flight Goes Viral
A man in the United States was fired from his job after being caught on video yelling homophobic, racist slurs during a flight.
-
Eye On Investment, Telangana Minister KTR Meets UK Healthcare Giant
Telangana Minister KT Rama Rao on Thursday held a meeting with Global R&D Head GSK Consumer Health, Franck Riot and discussed the expansion plans of GlaxoSmithKline, a healthcare company, for the state.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
UK Approves GlaxoSmithKline Drug, Appears Effective Against Omicron
British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it "retains activity" against the new Omicron variant.
-
GlaxoSmithKline, SK Bioscience Start Final Trial Of COVID-19 Jab
British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday.
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
Glaxo Head Optimistic COVID-19 Vaccine Widely Available In 2021
The chief executive of GlaxoSmithKline, the world's largest maker of vaccines, said she was optimistic the industry will be able to make an immunisation against COVID-19 widely available next year.
-
Pentagon Awards Glaxo $342 Million Contract For COVID Vaccines
The Pentagon on Thursday announced a $342 million contract has been awarded to British pharmaceutical giant GlaxoSmithKline to deliver "mass quantities of COVID-19 vaccines" to US troops.
-
Britain Nears 500 Million Pound Deal For Sanofi, GSK COVID-19 Vaccine: Report
Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, the Sunday Times reported.
-
French Drugmaker Sanofi Expects Approval Of COVID-19 Vaccine By Next Year
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
-
"World Will Need More Than One COVID-19 Vaccine," Says UK Drugmaker
The world will need more than one COVID-19 vaccine so drug companies must partner in the race to develop the weapons to fight the novel coronavirus, GlaxoSmithKline Chief Executive Officer Emma Walmsley said on Wednesday.
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
How Can Genetic Data Be Better Encrypted? Researchers Find A Way
Using nothing more than a simple vial of saliva, millions of people have created DNA profiles on genealogy websites.
-
Alphabet, GlaxoSmithKline Partner on Life Science Unit
Verily Life Sciences and GSK will together contribute GBP 540 million over seven years to the new bioelectronics firm
-
Pharma Giant GSK Fires Employee After Video Of His Abusive Meltdown On Flight Goes Viral
A man in the United States was fired from his job after being caught on video yelling homophobic, racist slurs during a flight.
-
Eye On Investment, Telangana Minister KTR Meets UK Healthcare Giant
Telangana Minister KT Rama Rao on Thursday held a meeting with Global R&D Head GSK Consumer Health, Franck Riot and discussed the expansion plans of GlaxoSmithKline, a healthcare company, for the state.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
UK Approves GlaxoSmithKline Drug, Appears Effective Against Omicron
British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it "retains activity" against the new Omicron variant.
-
GlaxoSmithKline, SK Bioscience Start Final Trial Of COVID-19 Jab
British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday.
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
Glaxo Head Optimistic COVID-19 Vaccine Widely Available In 2021
The chief executive of GlaxoSmithKline, the world's largest maker of vaccines, said she was optimistic the industry will be able to make an immunisation against COVID-19 widely available next year.
-
Pentagon Awards Glaxo $342 Million Contract For COVID Vaccines
The Pentagon on Thursday announced a $342 million contract has been awarded to British pharmaceutical giant GlaxoSmithKline to deliver "mass quantities of COVID-19 vaccines" to US troops.
-
Britain Nears 500 Million Pound Deal For Sanofi, GSK COVID-19 Vaccine: Report
Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, the Sunday Times reported.
-
French Drugmaker Sanofi Expects Approval Of COVID-19 Vaccine By Next Year
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
-
"World Will Need More Than One COVID-19 Vaccine," Says UK Drugmaker
The world will need more than one COVID-19 vaccine so drug companies must partner in the race to develop the weapons to fight the novel coronavirus, GlaxoSmithKline Chief Executive Officer Emma Walmsley said on Wednesday.
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
How Can Genetic Data Be Better Encrypted? Researchers Find A Way
Using nothing more than a simple vial of saliva, millions of people have created DNA profiles on genealogy websites.
-
Alphabet, GlaxoSmithKline Partner on Life Science Unit
Verily Life Sciences and GSK will together contribute GBP 540 million over seven years to the new bioelectronics firm
